Top global orphan drugs by revenue 2017

The data displays the top pharmaceutical orphan drugs worldwide based on the revenues in 2017. During that year, Revlimid marketed by Celgene was the world's top orphan drug, generating over eight billion USD in revenue. Orphan drugs are developed to treat a specific rare medical condition, often called an orphan disease. In many countries, public policy determines the characteristics behind specifying orphan diseases and drugs.